Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125746493 | 12574649 | 3 | F | 20160311 | 20160802 | 20160720 | 20160815 | EXP | JP-PFIZER INC-2016342343 | PFIZER | 47.00 | YR | F | Y | 0.00000 | 20160815 | PH | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125746493 | 12574649 | 1 | PS | AZULFIDINE EN-TABS | SULFASALAZINE | 1 | 1000 MG, DAILY | 7073 | 1000 | MG | MODIFIED-RELEASE TABLET | ||||||||
| 125746493 | 12574649 | 2 | SS | Celecox | CELECOXIB | 1 | Oral | 200 MG, DAILY | 20998 | 200 | MG | TABLET | |||||||
| 125746493 | 12574649 | 3 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, DAILY | 0 | 400 | MG | ||||||||
| 125746493 | 12574649 | 4 | SS | CIMZIA | CERTOLIZUMAB PEGOL | 1 | Subcutaneous | 400 MG, 1X/DAY | 0 | 400 | MG | QD | |||||||
| 125746493 | 12574649 | 5 | C | FOLIAMIN | FOLIC ACID | 1 | 5 MG, WEEKLY | 0 | 5 | MG | /wk | ||||||||
| 125746493 | 12574649 | 6 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | 20 MG, 1X/DAY | 0 | 20 | MG | CAPSULE | QD | |||||||
| 125746493 | 12574649 | 7 | C | RHEUMATREX | METHOTREXATE SODIUM | 1 | Oral | 10 MG, WEEKLY | 0 | 10 | MG | /wk | |||||||
| 125746493 | 12574649 | 8 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Rectal | 0 | GASTRO-RESISTANT TABLET | ||||||||||
| 125746493 | 12574649 | 9 | C | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | 0 | GASTRO-RESISTANT TABLET | |||||||||||
| 125746493 | 12574649 | 10 | C | FERROMIA | FERROUS CITRATE | 1 | 100 MG, DAILY | 0 | 100 | MG | |||||||||
| 125746493 | 12574649 | 11 | C | INAVIR /07146202/ | 2 | UNK | 0 | ||||||||||||
| 125746493 | 12574649 | 12 | C | PREDONINE | PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE | 1 | 5 MG, DAILY | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125746493 | 12574649 | 1 | Pain |
| 125746493 | 12574649 | 2 | Pain |
| 125746493 | 12574649 | 3 | Rheumatoid arthritis |
| 125746493 | 12574649 | 8 | Pyrexia |
| 125746493 | 12574649 | 9 | Influenza |
| 125746493 | 12574649 | 11 | Influenza |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125746493 | 12574649 | HO |
| 125746493 | 12574649 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125746493 | 12574649 | Influenza | |
| 125746493 | 12574649 | Nephritis | |
| 125746493 | 12574649 | Pyelonephritis | |
| 125746493 | 12574649 | Pyrexia | |
| 125746493 | 12574649 | Sepsis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125746493 | 12574649 | 1 | 20140205 | 0 | ||
| 125746493 | 12574649 | 2 | 20140205 | 0 | ||
| 125746493 | 12574649 | 3 | 20160304 | 20160304 | 0 | |
| 125746493 | 12574649 | 4 | 20160502 | 0 | ||
| 125746493 | 12574649 | 5 | 20140205 | 0 | ||
| 125746493 | 12574649 | 6 | 20140205 | 0 | ||
| 125746493 | 12574649 | 7 | 20140205 | 0 | ||
| 125746493 | 12574649 | 10 | 20140205 | 0 | ||
| 125746493 | 12574649 | 12 | 20140205 | 0 |